Reported Earnings • May 25
First quarter 2026 earnings released First quarter 2026 results: Net loss: kr2.73m (loss widened 6.6% from 1Q 2025). お知らせ • Apr 23
Biofrigas Sweden AB (publ) to Report Q1, 2026 Results on May 22, 2026 Biofrigas Sweden AB (publ) announced that they will report Q1, 2026 results on May 22, 2026 New Risk • Apr 04
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -kr15m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr15m free cash flow). Share price has been highly volatile over the past 3 months (1,338% average daily change). Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (66% increase in shares outstanding). Revenue is less than US$1m (kr1.5m revenue, or US$158k). Minor Risk Market cap is less than US$100m (€18.9m market cap, or US$21.8m). お知らせ • Apr 02
Biofrigas Sweden AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 14.862021 million. Biofrigas Sweden AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 14.862021 million.
Security Name: Ordinary Share
Security Type: Common Stock
Securities Offered: 74,310,104
Price\Range: SEK 0.2
Transaction Features: Rights Offering Reported Earnings • Mar 04
Full year 2025 earnings released: kr0.14 loss per share (vs kr0.17 loss in FY 2024) Full year 2025 results: kr0.14 loss per share. Net loss: kr11.4m (loss widened 17% from FY 2024). お知らせ • Jan 29
Biofrigas Sweden AB (publ) to Report Fiscal Year 2025 Results on Feb 27, 2026 Biofrigas Sweden AB (publ) announced that they will report fiscal year 2025 results on Feb 27, 2026 Reported Earnings • Nov 27
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: kr100.0k (down 92% from 3Q 2024). Net loss: kr2.53m (loss widened 19% from 3Q 2024). お知らせ • Oct 30
Biofrigas Sweden AB (publ) to Report Q3, 2025 Results on Nov 28, 2025 Biofrigas Sweden AB (publ) announced that they will report Q3, 2025 results on Nov 28, 2025 Reported Earnings • Sep 01
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: kr118.0k (down 97% from 2Q 2024). Net loss: kr3.34m (loss widened 8.2% from 2Q 2024). お知らせ • Jul 30
Biofrigas Sweden AB (publ) to Report First Half, 2025 Results on Aug 29, 2025 Biofrigas Sweden AB (publ) announced that they will report first half, 2025 results on Aug 29, 2025 Reported Earnings • May 23
First quarter 2025 earnings released First quarter 2025 results: Revenue: kr1.14m (down 22% from 1Q 2024). Net loss: kr2.56m (loss widened 45% from 1Q 2024). お知らせ • Apr 24
Biofrigas Sweden AB (publ) to Report Q1, 2025 Results on May 23, 2025 Biofrigas Sweden AB (publ) announced that they will report Q1, 2025 results on May 23, 2025 Reported Earnings • Feb 25
Full year 2024 earnings released: kr0.26 loss per share (vs kr0.48 loss in FY 2023) Full year 2024 results: kr0.26 loss per share. Revenue: kr8.93m (up 151% from FY 2023). Net loss: kr9.74m (loss widened 47% from FY 2023). お知らせ • Jan 23
Biofrigas Sweden AB (publ) to Report Fiscal Year 2024 Results on Feb 21, 2025 Biofrigas Sweden AB (publ) announced that they will report fiscal year 2024 results on Feb 21, 2025 Reported Earnings • Nov 24
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: kr1.18m (up 164% from 3Q 2023). Net loss: kr2.13m (loss widened 42% from 3Q 2023). お知らせ • Oct 24
Biofrigas Sweden AB (publ) to Report Q3, 2024 Results on Nov 22, 2024 Biofrigas Sweden AB (publ) announced that they will report Q3, 2024 results on Nov 22, 2024 Reported Earnings • Aug 25
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: kr3.50m (up 402% from 2Q 2023). Net loss: kr3.09m (loss widened 67% from 2Q 2023). お知らせ • Jul 25
Biofrigas Sweden AB (publ) to Report First Half, 2024 Results on Aug 23, 2024 Biofrigas Sweden AB (publ) announced that they will report first half, 2024 results on Aug 23, 2024 New Risk • Jul 14
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 175% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr8.3m free cash flow). Shares are highly illiquid. Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (175% increase in shares outstanding). Revenue is less than US$1m (kr3.4m revenue, or US$325k). Market cap is less than US$10m (€1.55m market cap, or US$1.69m). Board Change • Jul 05
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Director Per Hildor was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. 